Genetic Link Uncovered in Disparate Colon Cancer Death

	Tweet

A new study reveals the first-ever genetic link to the reason African-Americans are at increased risk of dying from colon cancer.

The discovery by researchers at the University of Alabama at Birmingham (UAB) is focused on a protein variant called Pro72 identified through genetic testing. In the study, African-Americans with a Pro72 protein variant had more than double the risk of dying from an advanced form of colon cancer compared to whites, the researchers said.

The discovery boosts the scientific understanding of racial disparities in cancer and other diseases and adds new detail in the ongoing search for more personalized cancer-fighting therapies, said Upender Manne, Ph.D., an associate professor in the UAB Department of Pathology who led the study.

The findings are published in the April 1 issue of the journal Clinical Cancer Research.

Pro72 is a molecule that arises from alterations in a tumor suppressor gene called p53, a gene that has been linked to half of all cancers in the world.

“This paper shows that in a subset of patients with the Pro72 variant, the susceptibility to disruptive p53 alterations may be a possible molecular explanation for the racial disparity,” said Manne, an associate scientist in the UAB Comprehensive Cancer Center.

The study included DNA analysis of 373 colorectal tumors. Researchers first sequenced the whole p53 gene in the tumors, and then analyzed the Pro72 frequency. Seventeen percent of African-Americans have a Pro72 variant, whereas only 7 percent of whites have the variant, Manne said.

UAB conducts community-based research and is a national leader in colorectal cancer prevention through its Minority Health & Health Disparities Research Center and treatment at the UAB Comprehensive Cancer Center.

Source: University of Alabama at Birmingham

RELATED STORIES:
Hydrophobic proteins: Potential biomarkers for colorectal cancer   City of Hope researchers to present rectal cancer, palliative care, benchmarking studies at ASCO   Use of Low-Dose Aspirin Associated with Improved Performance of Test for Detecting Colorectal Cancer   MRI predicts survival in locally advanced rectal cancer   Virtual colonoscopy an effective colorectal cancer screening exam in Medicare age patientsComputed t   Colonoscopy Prep Harder on Women than Men   Tests between colonoscopies could be lifesaver for high-risk patients   Chinese most prone to colorectal cancer in Asia   Bowel cancer: 8 years of colonoscopy screening in Germany—a success story   Hour of daily exercise cuts bowel cancer risk   Post-Treatment Diet Patterns Explored in Colorectal Cancer Patients   Fecal immunochemical testing best and most cost-effective method for screening for colorectal cancer   Diabetes & hyper-insulinemia as predictors of colorectal cancer risk   Lack of sleep found to be a new risk factor for colon cancer   Patients not receiving follow-up tests after positive screening for colon cancer   Regular Screenings and Healthy Living Reduce Colon Cancer Risk   Chemicals in curry and onions may help prevent colon cancer   Protein found in heart may be target for colon cancer therapies   Celebrex may prevent cancer but raises heart risks   Hormone replacement tied to lower colon cancer risk   Study showed oxaliplatin improved colon cancer patient survival   Wealth, health impact colon cancer screening

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]